Rationale and design of CASPER: compliance and quality of life study comparing once-daily carvedilol CR and twice-daily carvedilol IR in patients with heart failure. [electronic resource]
Producer: 20070220Description: 60L-66L p. digitalISSN:- 0002-9149
- Adrenergic beta-Antagonists -- administration & dosage
- Carbazoles -- administration & dosage
- Carvedilol
- Chemistry, Pharmaceutical
- Delayed-Action Preparations -- administration & dosage
- Heart Failure -- drug therapy
- Humans
- Patient Compliance
- Propanolamines -- administration & dosage
- Quality of Life
- Randomized Controlled Trials as Topic
- Research Design
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.